Your browser doesn't support javascript.
loading
Hydroxyurea at escalated dose versus fixed low-dose hydroxyurea in adults with sickle cell disease.
Ogu, Ugochi O; Mukhopadhyay, Ayesha; Patel, Kruti; Nelson, Marquita N; Strahan, KayLee S; Wu, Lin; Smeltzer, Matthew P; Ataga, Kenneth I.
Afiliação
  • Ogu UO; Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Mukhopadhyay A; Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Patel K; Division of Epidemiology, Biostatistics and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee, USA.
  • Nelson MN; Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Strahan KS; Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Wu L; Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Smeltzer MP; Northwest Campus Library, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Ataga KI; Research and Learning Services, Health Science Library, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Eur J Haematol ; 112(3): 466-474, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38019026
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article